FDA Inspection 1332850 — Retropsoas Technologies LLC

Retropsoas Technologies LLC — FEI 3031284747

The FDA completed an inspection of Retropsoas Technologies LLC on Aug 26, 2026 in Frontenac, MO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 26, 2026
Fiscal Year
2026
Product Type
Devices
Project Area
Compliance: Devices
Location
Frontenac, MO (United States)

Citations

IDCFRDescription
23170ISO 13485:2016 Clause 7.5.6Procedures for validation of processes lack required elements